🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to message these profiles privately for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in individuals administering products of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking fines, legal action or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the service has removed problematic content and prohibited related keywords and query recommendations. The company said it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.

Online Trading Operations

Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, populated with images of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

Within minutes of entering one group, a vendor posted WhatsApp details, where most transactions take place. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, health issues or previous experience.

Product Information and Costs

Inside these communities, posts display black plastic parcels with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they can’t verify. Although the research behind retatrutide is sound, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously seen patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to potentially serious health risks”.